* Biotricity Inc BTCY.OQ reported a quarterly adjusted
loss of 9
cents per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss of 7
cents per share.
* Revenue rose 31.7% to $2.38 million from a year ago;
analysts
expected $2.54 million.
* Biotricity Inc's reported EPS for the quarter was a loss
of 9
cents.
* The mean earnings estimate of analysts had risen by
about 36.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Biotricity Inc shares had risen by 27.5% this quarter and
lost 74.4% so far this year.
* The company reported a quarterly loss of $4.9 million.
* Wall Street's median 12-month price target for Biotricity
Inc is
$3.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
14 at 10:04 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.07 -0.09 Missed
Jun. 30 2022 -0.11 -0.10 Beat
Mar. 31 2022 -0.11 -0.11 Met
Dec. 31 2021 -0.16 -0.12 Beat